Biography

Claus G. Roehrborn, MD, was born and raised in West Germany. After attending Medical School in Giessen, Germany, he began his residency in surgery and urology at the German Army Hospital in Giessen. In 1984 he came to Dallas, Texas, and continued his urology residency at The University of Texas Southwestern Medical Center at Dallas. After finishing his residency in 1989 he won an AFUD Scholarship and worked for two years with Dr. Jean Wilson in the field of androgen regulation of prostate development and growth. In 1992 he joined the urology faculty at UT Southwestern, where he currently is Professor and Chairman of the Department of Urology. Dr Roehrborn’s practice focuses on the treatment of prostate cancer and BPH. He has performed over 1250 daVinci robotic prostatectomies for prostate cancer and over 700 laser prostatectomies for BPH. His research interests are in the areas of benign and malignant prostate diseases, including medical and minimally invasive therapies for BPH, and markers for prostate cancer. In addition, he has a background in urological ultrasound and has chaired numerous postgraduate courses and lectured on a variety of topics in ultrasound imaging of the urinary tract. His basic, translational and clinical research has yielded over 220 peer-reviewed publications, over 30 book chapters and numerous other contributions to the literature. Aside from being invited to give lectures all over the world, he has chaired or participated in many postgraduate courses and has been visiting professor at leading urological institutions in the US, Europe and Asia. Dr. Roehrborn has been the lead researcher for the 1994 AHCPR BPH Guidelines, and has been involved in the American Urological Association Guidelines efforts from their inception. He has chaired committees at the WHO-ICUD sponsored Consensus Conferences on BPH from 1994 throug 2005, and is co-chairman of the AUA BPH Guidelines Committee charged with an update of the AHCPR Guidelines from 1994. Dr. Roehrborn is on the editorial board of many peer-reviewed journals, associate editor of Urology, and co-editor of the comprehensive and authoritative Textbook of BPH. He serves as reviewer for nearly all peer-reviewed journals in the field of urology. At present, Dr. Roehrborn continues to be involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer.

Education

Medical School
Justus-Liebig-University Giessen (1980)
Internship
Army Hospital (1982), Surgery Urological
Residency
Army Hospital (1986), Surgery Urological
Fellowship
UT Southwestern Medical Center (1991), Surgery Urological
Residency
UT Southwestern Medical Center (1991), Surgery Urological

Research Interest

  • Benign prostatic hyperplasia
  • da Vinci Robotic Prostatectomy
  • Outcomes research
  • Prostate cancer
  • Tumor markers
  • Urological Ultrasound

Publications

Featured Publications LegendFeatured Publications

A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer.
Chang KH, Li R, Kuri B, Lotan Y, Roehrborn CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, Mirzaei H, Auchus RJ, Sharifi N Cell 2013 Aug 154 5 1074-84
Multi-Center Randomized Controlled Blinded Study of the Prostatic Urethral Lift for the Treatment of LUTS Associated with Prostate Enlargement Due to BPH: The L.I.F.T. Study.
Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield SK, Borges FD, Rukstalis DB J. Urol. 2013 Jun
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
Brock G, Broderick G, Roehrborn CG, Xu L, Wong D, Viktrup L BJU Int. 2013 May
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence
Karam JA, Lotan Y, Roehborn CG, Ashfaq R, Karakiewicz PI, Shariat SF Prostate 2007 67 614-622
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A J Clin Oncol 2007 25 2035-2041

Honors & Awards

  • Dallas Best Doctor 2004 - 2013
    Selected by peers in 2004 - 2013 (2004)
  • Texas Super Doctor 2004 - 2013
    Selected by peers in the state of Texas (2004)
  • SIU Guest Lecture
    Invited Guest Lecturer at the German Urological Meeting to give the SIU Guest Lecture (2002)
  • Special Recognition AUA Guidelines
    For extraordinary contributions to the AUA Guidelines Effort (1997)
  • Invited Visiting Professor and Lecturer
    Multiple Urological Organizations in over 30 countries (0)

Professional Associations/Affiliations

  • American Medical Association
  • American Urological Association (AUA)
  • European Association of Urology (EAU)
  • Societe Internationale Urologique (SIU)
  • South Central Section of the American Urological Association (SCS AUA)